HOME >> BIOLOGY >> NEWS
Joslin Diabetes Center in Boston establishes first affiliate in Canada

BOSTON-October 19, 2006-Joslin Diabetes Center, the global leader in diabetes research, care and education, has announced its partnership with Acadie-Bathurst Health Authority (ABHA) in New Brunswick, Canada. The new affiliate, which is located at Chaleur Regional Hospital, is Joslin's first Canadian Affiliate.

The new Joslin Affiliate is an Education Affiliate, so all of Joslin's premier education programs and services are shared with the institution. This will complement the endocrine services offered by Dr. Farrukh Khan a board-certified endocrinologist who serves as medical director.

"There is no doubt in my mind that the establishment of a Joslin Diabetes Center Education Affiliate right here in Bathurst is a major coup for residents of the region and the entire population of New Brunswick," stated Gabriel Godin, chair of the ABHA board of trustees.

"According to the Canadian Diabetes Association, more than 5.4 percent of the people in New Brunswick have diabetes, and as many as one-third of the population has diabetes but don't know they have the disease," said Judith Eyres Goodwin, director of Joslin's Affiliated Centers Program. "We look forward to working with the professionals at Chaleur Regional Hospital to bring Joslin's integrated, state-of-the-art education programs and services to people with diabetes and related conditions in the region."

"Our staff have received training from Joslin Diabetes Center in Boston to ensure that they follow the organization's standards closely in providing education to patients with diabetes in the Chaleur region and the Acadian Peninsula," said Alice Hbert, director of nursing for the ABHA.


'"/>

Contact: Jenny Eriksen
jenny.eriksen@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
19-Oct-2006


Page: 1

Related biology news :

1. Joslin study indicates insulin receptors play a critical role in promoting islet growth
2. Joslin researchers discover a surprising culprit in the search for causes of diabetic birth defects
3. Joslin study reveals how a specific fat type can protect against weight gain and diabetes
4. Joslin discovers protein that causes blood vessel leakage and swelling with diabetic retinopathy
5. Joslin-led study uncovers role of appetite hormone MCH in insulin production
6. Joslin Diabetes Center study examines insulin pump therapy in adolescents
7. Walgreens and Joslin Diabetes Center form broad alliance to improve diabetes outcomes
8. Joslin awards Victory Medal to New York man living 75 years with type 1 diabetes
9. Joslins new book demystifies nutrition and meal planning for people with diabetes
10. Joslin study refutes recent report that bone marrow can replenish female oocytes
11. Joslin discovers signs of residual islet cell function in people with long-term type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... 2016 Research and Markets has announced ... Markets and Companies" to their offering. ... , , ... various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies ... also based on biomarker. Currently the most important applications ...
(Date:12/5/2016)... 2016 According to the ... Products (Consumable, Instruments, Automated Cell Expansion System), Cells ... Cell Research, Cancer, and Cell-Based Research), End-users (Biopharmaceutical ... Global Revenue, Trends, Growth, Share, Size and Forecast ... global cell expansion market is expected to reach ...
(Date:12/5/2016)... RAPIDS, Mich. , Dec. 5, 2016 NxGen MDx announced ... "By bringing the test in house, we,ve been able to improve customer ... down for patients," says Alan Mack , CEO of NxGen MDx. ... , , ... in test volume has led to more job opportunities at the Grand ...
(Date:12/5/2016)... YORK , December 5, 2016 ... player worldwide, with almost $108 billion of revenue and ... $170 billion were spent on global biopharmaceuticals, and this ... This morning, Stock-Callers.com has lined up these four equities ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ...
Breaking Biology Technology:
Cached News: